Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution... – Containing or obtained from camellia
Reexamination Certificate
2008-12-15
2011-10-25
McCormick, Melenie (Department: 1655)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Containing or obtained from camellia
Reexamination Certificate
active
08043635
ABSTRACT:
The present invention relates to isolated bioactive compositions containing bioactive fractions derived from Theacea plants. The present invention also relates to bioactive topical formulations containing the bioactive compositions. The present invention further relates to methods of using the bioactive compositions of the present invention, including, for example, methods for inhibiting inflammatory activity in skin tissue of a mammal, for protecting skin tissue of a mammal from ultraviolet light-induced damage, and for normalizing skin disorders in skin tissue of a mammal. The present invention also relates to methods for isolating bioactive fractions derived from cell juice or a cell walls component aTheaceaplant.
REFERENCES:
patent: 2559459 (1951-07-01), Peebles et al.
patent: 3684520 (1972-08-01), Bickoff et al.
patent: 3775133 (1973-11-01), Batley, Jr.
patent: 3799806 (1974-03-01), Madsen
patent: 3821346 (1974-06-01), Batley, Jr.
patent: 3823128 (1974-07-01), Bickoff et al.
patent: 3849391 (1974-11-01), Egger et al.
patent: 3959246 (1976-05-01), Bickoff et al.
patent: 3993794 (1976-11-01), Bernardin
patent: 4006078 (1977-02-01), Bickoff et al.
patent: 4066633 (1978-01-01), Gastineau et al.
patent: 4072666 (1978-02-01), Horisberger et al.
patent: 4077950 (1978-03-01), White
patent: 4130553 (1978-12-01), Batley, Jr.
patent: 4208323 (1980-06-01), Murray et al.
patent: 4233210 (1980-11-01), Koch
patent: 4234620 (1980-11-01), Howard et al.
patent: 4250197 (1981-02-01), Koch
patent: 4333871 (1982-06-01), DeJong
patent: 4334024 (1982-06-01), Johal
patent: 4347324 (1982-08-01), Wildman et al.
patent: 4359530 (1982-11-01), Brown
patent: 4421682 (1983-12-01), Edwards et al.
patent: 4551341 (1985-11-01), Blanie et al.
patent: 4559230 (1985-12-01), David et al.
patent: 4588691 (1986-05-01), Johal
patent: 4897345 (1990-01-01), Harris et al.
patent: 5043427 (1991-08-01), Leberre et al.
patent: 5096719 (1992-03-01), Gresch
patent: 5433968 (1995-07-01), Zarraga et al.
patent: 5530103 (1996-06-01), Livey et al.
patent: 5616357 (1997-04-01), Hartmann
patent: 5723149 (1998-03-01), Bonte et al.
patent: 5762994 (1998-06-01), Juillerat et al.
patent: 5777080 (1998-07-01), Boatright
patent: 5798446 (1998-08-01), Neumuller
patent: 5882664 (1999-03-01), Soma et al.
patent: 5989557 (1999-11-01), Bombardelli et al.
patent: 5994508 (1999-11-01), Bryan et al.
patent: 6013771 (2000-01-01), Shen et al.
patent: 6037456 (2000-03-01), Garger et al.
patent: 6060061 (2000-05-01), Breton
patent: 6068862 (2000-05-01), Ishihara et al.
patent: 6107468 (2000-08-01), Boatright
patent: 6139825 (2000-10-01), Reinhard et al.
patent: 6147054 (2000-11-01), De Paoli Ambrosi
patent: 6610749 (2003-08-01), Liao et al.
patent: 6616952 (2003-09-01), Berquist
patent: 2003/0113797 (2003-06-01), Jia et al.
patent: 1039525 (1990-02-01), None
patent: 1144652A (1997-03-01), None
patent: 2 054 343 (1981-02-01), None
patent: 57-146715 (1982-09-01), None
patent: 05-229921 (1993-09-01), None
patent: 09202726 (1997-08-01), None
patent: 11-001686 (1999-01-01), None
patent: 2001112817 (2001-12-01), None
patent: 01/72319 (2001-10-01), None
Dvorakova et al. Pharmacokinetics of the Green Tea Derivative EGCG by the Topical Route of Administration in Mouse and Human Skin. Cancer Chemother Pharmacol. (1999) 43:331-335.
Katiyar et al. Polyphenolic Antioxidant (=) Epigallocatechin-3-Gallate From Green Tea Reduces UVB-Induced Inflammatory Responses and Infiltration of Leukocytes in Human Skin. Phytochemistry and Photobiology. 1999. 69 (2) 148-153.
Tedeshi et al. Antiinflammatory Action of EGCG, The Main Component of Green Tea, Through STAT-1 Inhibition. Ann. N.Y. Acad. Sci. 973:2002. 435-437.
Lu et al. Topical Applications of Caffeine or (=)-Epigallocatechin Gallate (EGCG) Inhibit Carcinogenisis and Selectively Increase Apoptosis in UVB-Induced Skin Tumors in Mice. PNAS. 2002. 12455-12460.
Epidermoid cyst. Retrieved from the internet. <http://en.wikipedia.org/wiki/Epidermoid—cyst>. Retrieved on Mar. 22, 2010. pp. 1-2.
The Spectator. Sun Can Harm You Most During Middle Part of the Day. Jul. 6, 2002. p. K 03. (p. 1 of ProQuest).
Kinjo et al. Activity-Guided Fractionation of Green Tea Extract With Antiproliferative Activity Against Human Stomach Cancer Cells. Biol. Pharm. Bull. 25 (9) 2002. 1238-1240.
MTT assay. Retrieved from the internet. <http://en.wikipedia.org/wiki/MTT—assay>. Retrieved on Mar. 22, 2010. pp. 1-2.
Theacea. Retrieved from the internet<http://en.wikipedia.org/wiki/Theaceae>. Retrieved on Mar. 25, 2010. pp. 1-2.
WebMD. retrieved from the internet. <http://www.webmd.com/melanoma-skin-cancer/skin-cancer-guide/protecting-your-skin-from-ultraviolet-radiation-and-skin-cancer>. Retrieved on Mar. 22, 2010. pp. 1-4.
Merk. Skin Disorders. Retrieved from the internet. <http://www.merk.com/mmhe/sec18.html>. Retrieved on Mar. 22, 2010. pp. 1-2.
Camellia. retrieved from the internet. <http://en.wikipedia.org/wiki/Camellia>. Retrieved on Dec. 1, 2010. 1 page.
Sakata et al. Cyanidin 3-Galactoside, a New Anthocyanin fromCamellia japonicasubsp.rusticana(Honda) Kitamura and Its Occurrence in the Garden Froms ofCamelliaof Japanese Origin. J. Japan Soc. Hort. Sci. 55 (1). 1986. pp. 82-88.
Supplementary European Search Report issued in European Patent Application No. 05711431.6 (based on PCT/US2005/001132), dated Jul. 9, 2009.
Okai et al., “Potent Suppressive Activity of Nonpolyphenolic Fraction of Green Tea (Camellia sinensis) Against Genotoxin-InducedumuC Gene Expression inSalmonella typhimurium(TA 1535/pSK 1002), Tumor Promoter-Dependent Ornithine Decarboxylase Induction of BALB/c 3T3 Fibroblast Cells, and Chemically Induced Mouse Skin Tumorigenesis,”Teratogenesis, Carcinogenesis, and Mutagenesis, 17(6):305-312 (1997).
Matsui et al., “Fatty Acid Hydroperoxide Cleaving Enzyme, Hydroperoxide Lyase, From Tea Leaves,”Phytochemistry, 30(7):2109-2113 (1991).
Gensler et al., “Prevention of Photocarcinogensis by Topical Administration of Pure Epigallocatechin Gallate Isolated From Green Tea,”Nutrition and Cancer, 26(3):325-335 (1996).
Zhao et al., “Photoprotective Effect of Black Tea Extracts Against UVB-Induced Phototoxicity in Skin,”Photochemistry and Photobiology, 70(4):637-644 (1999).
Vayalil et al., “Treatment of Green Tea Polyphenols in Hydrophilic Cream Prevents UVB-Induced Oxidation of Lipids and Proteins, Depletion of Antioxidant Enzymes and Phosphorylation of MAPK Proteins in SKH-1 Hairless Mouse Skin,”Carcinogenesis, 24(5):927-936 (2003).
Huang et al., “Effects of Tea, Decaffeinated Tea, and Caffeine on UVB Light-Induced Complete Carcinogenesis in SKH-1 Mice: Demonstration of Caffeine as a Biologically Important Constituent of Tea,”Cancer Research, 57(13):2623-2629 (1997).
Bray, “Green Crop Fractionation: Product Improvement by Juice Purification,”Progress in Leaf Protein Research, 129-142 (1984).
Byers, “Extracted Leaf Proteins: Their Amino Acid Composition and Nutritional Quality,”Leaf Protein Concentrates, 5:135-175 (Telek and Graham eds. 1983).
Carroad et al., “Optimization of Cell Disruption for Alfalfa Leaf Protein Concentration (Pro-Xan) Production,”Journal of Food Science, 46:383-386 (1981).
Clifford et al., “Nucleic Acid Content and Nutritional Value of Green and White Leaf Proteins of Alfalfa,”Nutrition Reports International, 15(5):511-518 (1977).
Hanczakowski et al., “Composition and Nutritive Value of Native and Modified Green Fraction of Leaf Protein Lucerne (Medicago sativa),”Journal of Science Food and Agriculture, 56(4):495-501 (1991).
He et al., “The Comparison on Extraction Methods of Leaf Protein,”Journal of Plant Resources and Environment, 8(2):63-64 (1999) (English Abstract).
Hughes et al., “The Subcellular Distribution of Tocopherols in the Green Leaves ofPisum sativum,” Biochemical Journal, 124(2):9P-10P (1971).
Jwanny et al., “Protein Production for Human Use Fr
Akzo Nobel Surface Chemistry LLC
Gonsalves Andrew K.
Heslin Rothenberg Farley & & Mesiti P.C.
McCormick Melenie
LandOfFree
Bioactive compositions from Theacea plants and processes... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioactive compositions from Theacea plants and processes..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioactive compositions from Theacea plants and processes... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4289030